Acadia Healthcare (NASDAQ:ACHC) Shares Pass Above 200-Day Moving Average – Here’s What Happened

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $20.81 and traded as high as $27.73. Acadia Healthcare shares last traded at $27.69, with a volume of 2,456,146 shares changing hands.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ACHC. UBS Group upped their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the stock a “buy” rating in a report on Friday, April 17th. Cantor Fitzgerald lifted their price target on shares of Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a research note on Monday, May 4th. Finally, KeyCorp reiterated an “overweight” rating and set a $30.00 price target on shares of Acadia Healthcare in a research report on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $26.85.

Acadia Healthcare Stock Performance

The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The stock has a 50-day moving average price of $25.47 and a 200 day moving average price of $20.92. The company has a market cap of $2.87 billion, a price-to-earnings ratio of -2.55, a price-to-earnings-growth ratio of 9.24 and a beta of 0.69.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.28 by $0.09. The firm had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period last year, the company posted $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. EverSource Wealth Advisors LLC boosted its stake in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the last quarter. Wells Fargo & Company MN lifted its holdings in Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the last quarter. Bayforest Capital Ltd bought a new stake in shares of Acadia Healthcare during the 4th quarter worth about $52,000. GAMMA Investing LLC grew its position in shares of Acadia Healthcare by 124.7% in the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after purchasing an additional 2,698 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its holdings in Acadia Healthcare by 4,264.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock valued at $76,000 after buying an additional 5,203 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.